EP300 and carcinoma: Importantly, we find that SnoN acts in a sumoylation-dependent fashion to stimulate and inhibit, respectively, the effects of HDAC1 and p300 on EMT-associated morphological and functional changes in breast epithelial and carcinoma cells.